ISDA

Deposition Date 2013-02-05

Release Date 2013-05-22

Last Version Date 2024-05-08

Entry Detail

PDB ID:

3ZM4

Keywords:

TRANSFERASE

Title:

Crystal structure of MEK1 in complex with fragment 1

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

SPODOPTERA FRUGIPERDA

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.37 Å

R-Value Free:

0.24

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 61 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1
Gene (Uniprot):MAP2K1
Mutations:YES
Chain IDs:A
Chain Length:348
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:Q02750 Pfam ID:PF00069 EC:2.7.12.2

Ligand Molecules

22T

Primary Citation

The Use of Virtual Screening and Differential Scanning Fluorimetry for the Rapid Identification of Fragments Active Against Mek1.

Amaning, K, Lowinski, M, Vallee, F, Steier, V, Marcireau, C, Ugolini, A, Delorme, C, Foucalt, F, Mccort, G, Derimay, N, Andouche, C, Vougier, S, Llopart, S, Halland, N, Rak, A.Show

Bioorg.Med.Chem.Lett. 23 3620 ? (2013)

PMID: 23648182 DOI: 10.1016/J.BMCL.2013.04.003

Abstact

We report the analysis of an in-house fragment screening campaign for the oncology target MEK1. The application of virtual screening (VS) as a primary fragment screening approach, followed by biophysical validation using differential screening fluorimetry (DSF), with resultant binding mode determination by X-ray crystallography (X-ray), is presented as the most time and cost-effective combination of in silico and in vitro methods to identify fragments. We demonstrate the effectiveness of the VS-DSF workflow for the early identification of fragments to both 'jump-start' the drug discovery project and to complement biochemical screening data.

Legend

Protein

Chemical

Disease

Primary Citation of related structures